Filing Details

Accession Number:
0001209191-21-012522
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-19 18:21:13
Reporting Period:
2021-02-17
Accepted Time:
2021-02-19 18:21:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1584751 Talis Biomedical Corp TLIS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1333482 J Kimberly Popovits C/O Talis Biomedical Corporation
230 Constitution Drive
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-17 22,041 $0.00 25,776 No 4 C Direct
Common Stock Acquisiton 2021-02-17 209,790 $0.00 209,790 No 4 C Indirect By spouse
Common Stock Acquisiton 2021-02-17 5,300 $16.00 215,090 No 4 P Indirect By spouse
Common Stock Acquisiton 2021-02-17 92,057 $0.00 92,057 No 4 C Indirect By MSL FBO Kimberly J. Popovits Patrick J. Popovits TTEE U/A/D 05- 17-2010 FBO Popovits 2010 Trust
Common Stock Acquisiton 2021-02-17 89,968 $0.00 182,025 No 4 C Indirect By MSL FBO Kimberly J. Popovits Patrick J. Popovits TTEE U/A/D 05- 17-2010 FBO Popovits 2010 Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Indirect By spouse
No 4 P Indirect By spouse
No 4 C Indirect By MSL FBO Kimberly J. Popovits Patrick J. Popovits TTEE U/A/D 05- 17-2010 FBO Popovits 2010 Trust
No 4 C Indirect By MSL FBO Kimberly J. Popovits Patrick J. Popovits TTEE U/A/D 05- 17-2010 FBO Popovits 2010 Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series C-1 Preferred Stock Disposition 2021-02-17 31,519 $0.00 22,041 $0.00
Common Stock Series E-1 Preferred Stock Disposition 2021-02-17 300,000 $0.00 209,790 $0.00
Common Stock Series E-1 Preferred Stock Disposition 2021-02-17 131,642 $0.00 92,057 $0.00
Common Stock Series F-1 Preferred Stock Disposition 2021-02-17 128,655 $0.00 89,968 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Each share of Series C-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series C-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series C-1 Preferred Stock.
  2. Each share of Series E-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series E-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series E-1 Preferred Stock.
  3. Ms. Popovits and her spouse are trustees of the MSL FBO Kimberly J. Popovits Patrick J. Popovits TTEE U/A/D 05-17-2010 FBO Popovits 2010Trust and share voting and dispositive power.
  4. Each share of Series F-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series F-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series F-1 Preferred Stock.